136 related articles for article (PubMed ID: 18791442)
1. Human leukocyte antigen class II antibodies and transplant outcome.
Duquesnoy RJ
Transplantation; 2008 Sep; 86(5):638-40. PubMed ID: 18791442
[No Abstract] [Full Text] [Related]
2. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Süsal C; Döhler B; Opelz G
Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
[TBL] [Abstract][Full Text] [Related]
3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
4. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
[TBL] [Abstract][Full Text] [Related]
5. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells.
Young E; Stark WJ; Prendergast RA
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):571-4. PubMed ID: 3884541
[TBL] [Abstract][Full Text] [Related]
6. [HLA-DR and kidney transplant].
Andreu J; Esteller E
Med Clin (Barc); 1983 Mar; 80(7):327-33. PubMed ID: 6222226
[No Abstract] [Full Text] [Related]
7. The role of anti-class II HLA antibodies in heart transplantation.
Nikaein A; Alivizatos PA; Monahan K; Stone MJ
Transplantation; 1995 Feb; 59(3):439-42. PubMed ID: 7871580
[No Abstract] [Full Text] [Related]
8. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
9. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape.
Zwart W; Griekspoor A; Kuijl C; Marsman M; van Rheenen J; Janssen H; Calafat J; van Ham M; Janssen L; van Lith M; Jalink K; Neefjes J
Immunity; 2005 Feb; 22(2):221-33. PubMed ID: 15723810
[TBL] [Abstract][Full Text] [Related]
10. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
11. Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood.
El-Awar N; Terasaki PI; Nguyen A; Sasaki N; Morales-Buenrostro LE; Saji H; Maruya E; Poli F
Hum Immunol; 2009 Oct; 70(10):844-53. PubMed ID: 19580837
[TBL] [Abstract][Full Text] [Related]
12. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
Duquesnoy RJ; Marrari M
Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
[TBL] [Abstract][Full Text] [Related]
13. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
[TBL] [Abstract][Full Text] [Related]
14. Human leukocyte antigen antibodies and chronic rejection: from association to causation.
Terasaki PI; Cai J
Transplantation; 2008 Aug; 86(3):377-83. PubMed ID: 18698239
[TBL] [Abstract][Full Text] [Related]
15. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
Kaczmarek I; Deutsch MA; Kauke T; Beiras-Fernandez A; Schmoeckel M; Vicol C; Sodian R; Reichart B; Spannagl M; Ueberfuhr P
Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
[TBL] [Abstract][Full Text] [Related]
16. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte histocompatibility antigen class II-induced cytokines from human gingival fibroblasts promote proliferation of human umbilical vein endothelial cells: potential association with enhanced angiogenesis in chronic periodontal inflammation.
Okada Y; Meguro M; Ohyama H; Yoshizawa S; Takeuchi-Hatanaka K; Kato N; Matsushita S; Takashiba S; Nishimura F
J Periodontal Res; 2009 Feb; 44(1):103-9. PubMed ID: 19515021
[TBL] [Abstract][Full Text] [Related]
18. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of anti-HLA antibodies via proteasome inhibition.
Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
[TBL] [Abstract][Full Text] [Related]
20. Four short projects about antibodies, soluble CD30, and organ transplant rejection.
Stastny P; Spells K; Rogers J; Zou Y; Lavingia B
Clin Transpl; 2006; ():337-47. PubMed ID: 18365388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
